212 related articles for article (PubMed ID: 9291322)
1. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
[TBL] [Abstract][Full Text] [Related]
2. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of recurrent vulvovaginal candidiasis.
Fidel PL; Sobel JD
Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
[TBL] [Abstract][Full Text] [Related]
4. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
[TBL] [Abstract][Full Text] [Related]
5. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
[TBL] [Abstract][Full Text] [Related]
6. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
[TBL] [Abstract][Full Text] [Related]
7. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
[TBL] [Abstract][Full Text] [Related]
8. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
9. [Local humoral immunity in vulvovaginal candidiasis].
Amouri I; Hadrich I; Abbes S; Sellami H; Ayadi A
Ann Biol Clin (Paris); 2013; 71(2):151-5. PubMed ID: 23587578
[TBL] [Abstract][Full Text] [Related]
10. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
[TBL] [Abstract][Full Text] [Related]
11. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
12. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
Witkin SS; Jeremias J; Ledger WJ
J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
Wozniak KL; Palmer G; Kutner R; Fidel PL
Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
[TBL] [Abstract][Full Text] [Related]
14. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
15. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
Taylor BN; Saavedra M; Fidel PL
Med Mycol; 2000 Dec; 38(6):419-31. PubMed ID: 11204879
[TBL] [Abstract][Full Text] [Related]
16. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid.
Weissenbacher TM; Witkin SS; Gingelmaier A; Scholz C; Friese K; Mylonas I
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):59-63. PubMed ID: 19261373
[TBL] [Abstract][Full Text] [Related]
17. Microbicidal activity of neutrophils is inhibited by isolates from recurrent vaginal candidiasis (RVVC) caused by Candida albicans through fungal thioredoxin reductase.
Ratti BA; Godoy JS; de Souza Bonfim Mendonça P; Bidóia DL; Nakamura TU; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; de Oliveira Silva S
Cell Immunol; 2015 Jan; 293(1):22-9. PubMed ID: 25497972
[TBL] [Abstract][Full Text] [Related]
18. Local expression of vaginal Th1 and Th2 cytokines in murine vaginal candidiasis under different immunity conditions.
Chen S; Li S; Wu Y; Liu Z; Li J
J Huazhong Univ Sci Technolog Med Sci; 2008 Aug; 28(4):476-9. PubMed ID: 18704316
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
[TBL] [Abstract][Full Text] [Related]
20. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
